Abstract
Alzheimer’s disease (AD) is characterized by progressive memory loss and cognitive decline. These impairments correlate with early alterations in neuronal network activity in AD patients. Disruptions in the activity of individual neurons have been reported in mouse models of amyloidosis. However, the impact of amyloid pathology on the spontaneous activity of distinct neuronal types remains unexplored in vivo. Here we use in vivo calcium imaging with multiphoton microscopy to monitor and compare the activity of excitatory and two types of inhibitory interneurons in the cortices of APP/PS1 and control mice under isoflurane anesthesia. We also determine the relationship between amyloid accumulation and the deficits in spontaneous activity in APP/PS1 mice. We show that somatostatin-expressing (SOM) interneurons are hyperactive, while parvalbumin-expressing interneurons are hypoactive in APP/PS1 mice. Only SOM interneuron hyperactivity correlated with proximity to amyloid plaque. These inhibitory deficits were accompanied by decreased excitatory neuron activity in APP/PS1 mice. Our study identifies cell-specific neuronal firing deficits in APP/PS1 mice driven by amyloid pathology. These findings highlight the importance of addressing the complexity of neuron-specific deficits to ameliorate circuit dysfunction in Alzheimer’s disease.
Subject terms: Alzheimer's disease, Neural circuits, Cellular neuroscience
Interneuron-specific lines reveal that somatostatin interneurons are hyperactive whereas pyramidal neurons and PV interneurons are ‘hypoactive’ in the APP/PS1 mouse model of Alzheimer’s Disease.
Introduction
Alzheimer’s disease (AD) is the most common form of dementia and the most prevalent neurodegenerative disorder in the United States1. The primary pathological hallmarks of Alzheimer’s disease include deposits of extracellular amyloid plaques as well as intracellular tau tangles, and eventually neuronal death2,3. Notably, the accumulation of amyloid-beta peptides is associated with aberrant neuronal activity and oscillatory network alterations in AD patients4 and in animal models5–8. Particularly, deficits in cognition-linked brain rhythms such as gamma and slow waves are prevalent in AD patients9,10. These neuronal activity alterations appear at the early stages of AD and correlate with the severity of cognitive impairment in AD patients11,12. Oscillatory brain rhythms are generated by complex firing patterns of individual neurons and interactions between neuronal populations across different brain regions13–15. Thus, there is an urgent need to understand the single-cell neuronal activity patterns in AD to restore the impaired oscillatory brain rhythms and improve cognitive function.
Several studies have assessed single-cell neuronal activity in amyloidosis mouse models in ex-vivo brain slices16–19 and in vivo5,20,21. While ex-vivo studies have monitored cell-type-specific neuronal activity, in vivo studies did not discriminate between neuronal subtypes and mainly reported the activity of excitatory neurons, which represent 80–90% of cortical neurons22. These reports have provided mixed findings of aberrant neuronal hyperactivity5,6 and hypoactivity5,21.
In addition to excitatory cells, ~10–20% of cortical neurons are inhibitory interneurons that display a wide variety of morphological and electrophysiological properties22–25. Despite constituting a small percentage, interneurons play an essential role in cortical computations and the maintenance of spontaneous network oscillations24. Interneurons are classified based on their protein expression profiles into distinct subtypes including somatostatin (SOM)- and parvalbumin (PV)-expressing interneurons, as well as others26. SOM and PV interneurons shape excitatory activity by targeting different cellular compartments of pyramidal cells24.
The function of specific interneuronal cell types is impaired in AD27,28. Particularly, PV interneuron dysfunction received considerable attention because of its role in gamma oscillatory activity27,29. For instance, hypoactivity17,18,29–32 and hyperactivity19 of PV interneurons were reported in several AD mouse models of amyloidosis. The firing activity of SOM interneurons in AD mouse models remains unexplored, but impairments in synaptic rewiring of hippocampal SOM interneurons was reported28. These cell-type-specific dysfunctions disrupt the well-regulated excitation and inhibition (E/I) balance resulting in broader, circuit-level dysfunction in AD27. Whether all interneuronal types are affected similarly in AD and whether their function is directly affected by amyloid plaques remains unclear.
During action potential firing, calcium ions (Ca2+) enter neurons through voltage gated calcium channels resulting in intracellular Ca2+ concentration changes33. As result, calcium imaging has been widely used as a proxy of neuronal action potential firing20,34,35.
Here, we determined the effect of amyloid-beta accumulation on the spontaneous activity of three distinct neuronal populations within cortical layers 2/3. To this end, we monitored the activity of excitatory neurons and two major classes of inhibitory interneurons, PV and SOM, in anesthetized APP/PS1 mice and non-transgenic littermates (WT) using the genetically encoded calcium indicator GCaMP.
We show that SOM interneurons are hyperactive, while PV and excitatory neurons are hypoactive in APP/PS1 mice. Furthermore, SOM interneurons located near amyloid plaques are more active than those located farther away. Finally, pairwise neuronal correlations of excitatory neurons show a strong trend for a decrease in APP/PS1 mice.
Results
SOM interneurons are hyperactive near amyloid plaques in APP/PS1 mice
The impact of AD on inhibitory interneuron cell-type-specific spontaneous activity is not well understood, with cortical SOM interneuron activity totally unexplored in vivo. Here, we performed in vivo multiphoton calcium imaging in anesthetized APP/PS1 (APP) mice and non-transgenic littermates (WT), to study cell-type-specific spontaneous neuronal activity.
We first monitored calcium transients in the somas of SOM interneurons using the genetically encoded calcium indicator jGCaMP7s (Fig. 1a). To target SOM interneurons selectively, we injected FLEX-jGCAMP7s into the somatosensory cortex of WT-SOM and APP-SOM mice (Fig. 1a). SOM interneurons exhibited spontaneous calcium transients in WT-SOM (Fig. 1b) and WT-APP (Fig. 1c) mice. We then estimated the number of deconvolved calcium events as a proxy measure for neuronal action potential firing (Supplementary Figure 1, Supplementary Movie 1). Due to the slower timescale of calcium indicator responses relative to action potential-related voltage changes, deconvolution of the calcium signal to the best estimate of spiking activity is required33,34. Several calcium deconvolution algorithms have been developed to address this non-trivial issue36–39. We chose to use a non-negative deconvolution algorithm39,40 to estimate the timing and the number of deconvolved calcium events in our recordings because it outperformed all other algorithms in a dataset of mutual calcium imaging and ground-truth electrophysiology recordings41. Our results show that SOM interneuron event rates were 2.7-fold higher in APP-SOM mice relative to WT-SOM mice (Fig. 1d, e). The fraction of inactive SOM cells was not different between conditions (Fig. 1f). Thus, SOM interneurons are hyperactive in APP/PS1 mice.
Studies examining spontaneous activity in indiscriminate neuronal populations in vivo have shown that neurons near amyloid plaques at distances less than 60 µm are more active than those farther away5. Therefore, to understand the relationship between amyloid plaques and the observed hyperactivity, we measured the correlation between SOM interneuron event rates and distance to amyloid plaques in APP/PS1 mice. We found a significant negative correlation between SOM interneuron activity and distance to amyloid plaques in APP/PS1 mice (Fig. 1g). SOM interneurons near amyloid plaques (<60 µm) were more active compared to those located away from plaques (Fig. 1h). Therefore, SOM interneuron hyperactivity is correlated with proximity to amyloid plaques.
Postmortem immunohistochemical analysis of WT-SOM mice confirmed that ~90% of jGCaMP7s cells were positive for SOM (Supplementary Fig. 2a, b), thus jGCaMP7s targeted SOM interneurons with high selectivity.
PV interneurons are hypoactive in APP/PS1 mice
We then asked whether the spontaneous hyperactivity in the somatosensory cortex can be generalized to other interneuron subtypes in APP/PS1 mice in vivo. PV interneurons have markedly different electrophysiological properties relative to SOM interneurons as they can reach very high firing rates42. Hence, we next used similar experimental procedures (Fig. 2a) and targeted jGCaMP7s expression to PV interneurons in the somatosensory cortex of WT-PV-Cre (WT-PV) (Fig. 2b) and APP-PV-Cre (APP-PV) mice (Fig. 2c). Mean event rates were 5.6-fold higher in WT-PV interneurons (Fig. 2d, Supplementary Movie 2, and Supplementary Fig. 3) relative to WT-SOM interneurons (Fig. 1d; mean ± s.e.m.: 0.18 ± 0.03 for PV interneurons, and 0.032 ± 0.01 for SOM interneurons). Contrary to our findings in SOM interneurons, PV interneurons showed a 1.8-fold decrease in event rates in APP-PV mice relative to WT-PV mice (Figs. 2d, e). The fraction of inactive PV cells was comparable across conditions (Fig. 2f). PV interneuron activity did not correlate with proximity to amyloid plaques (Fig. 2g, h). Therefore, PV interneurons are hypoactive in APP/PS1 mice irrespective of their proximity to amyloid plaques. These results suggest a cell-type-specific disruption in cortical interneuron activity of APP/PS1 mice.
Postmortem immunohistochemical analysis of PV-Cre mice confirmed that 86% of jGCaMP7s cells were positive for PV (Supplementary Fig. 2c, d).
Excitatory neurons are hypoactive in APP/PS1 mice
The disrupted interneuronal activity of APP/PS1 mice prompted us to investigate whether this deficit is related to E/I imbalance. SOM and PV interneurons form inhibitory synaptic contacts onto excitatory neurons, therefore dominant hypoactivity in either or both interneuron subtypes can potentially result in hyperactivity of excitatory cells. Because of the numerous reports of hyperactive cells in APP/PS1 mice in vivo, we hypothesized that excitatory cells are hyperactive as a result of dominant hypoactivity in PV interneurons. To test this hypothesis, we imaged spontaneous activity of layer 2/3 excitatory neurons of the somatosensory cortex in WT (WT-EX) and APP/PS1 (APP-EX) mice. We targeted excitatory neurons using a human CaMKIIα promoter to drive the expression of GCaMP6s (Fig. 3a–c). These recordings were performed on a combination of SOM-and PV-Cre mice to ensure comparability to interneuron recordings (see methods). In contrast to our hypothesis, excitatory neurons of APP-EX mice showed 1.6-fold lower event rates (Fig. 3d and Supplementary Movie 3) relative to WT-EX mice, with an overall lower cumulative distribution of event rates across all recorded cells (Fig. 3e). Mean event rates of excitatory cells were stable over 2 to 3 months (Supplementary Fig. 4) and did not depend on sex or mouse model (Supplementary Fig. 5). No significant change in the fractions of inactive excitatory cells (Fig. 3f) was observed. Excitatory neuron activity did not depend on amyloid plaque distance (Fig. 3g, h and Supplementary Movie 4). Therefore, cortical excitatory neurons are hypoactive in APP/PS1 mice irrespective of their proximity to amyloid plaques. To confirm that the cell-type-specific findings reported here are not driven by the analysis method, we reanalyzed the normalized fluorescence traces for all cell types using peak counting5,43. Peak counting showed similar results compared to non-negative deconvolution for excitatory and SOM interneurons (Supplementary Fig. 6). Although PV interneuron activity was not significantly different between groups using peak counting (Supplementary Fig. 6c), the cumulative frequency distribution of event rates was different in PV-APP interneurons relative to PV-WT interneurons (Supplementary Fig. 6d). In summary, while the analysis method has a minimal effect on most of our findings, PV interneuron results are limited and should be interpreted cautiously.
Pairwise neuronal correlations in APP/PS1 mice
To evaluate the impact of amyloid accumulation on the activity synchrony of different cell types, we calculated the Pearson correlation values (ρ) for all possible pairwise combinations of active neurons within the somatosensory cortex. Mean correlation values showed a trend for a decrease in APP-EX relative to WT-EX mice (Fig. 4a and Supplementary Figs. 7a and 8). It is established that neuronal synchrony decreases as the distance between neurons increases44. Therefore, we determined the relationship between correlation values and pairwise distance between neurons (Fig. 4b). As expected, correlation values decreased as a function of increased inter-neuronal distance, a phenomenon that seemed to be similar in WT-EX and APP-EX mice (Fig. 4b and Supplementary Fig. 7b). Since correlations are known to increase when neuronal event rates increase45, we also examined the relationship between mean correlations of a given neuron and its event rate. Excitatory neuronal ρ values increased as function of neuronal event rates (Fig. 4c, and Supplementary Fig, 7c). These observations did not significantly differ in WT-EX and APP-EX mice (Fig. 4c and Supplementary Fig. 7c), suggesting that the decreased correlation values in APP-EX mice are related to decreased event rates and not synchrony. We calculated significantly fewer pairwise correlations for interneurons relative to excitatory cells because only a few cells could be recorded in each imaging frame. Nevertheless, there was no significant change in correlation values for SOM and PV interneurons in APP/PS1 mice relative to WT (Fig. 4d, e and Supplementary Fig. 7d, e).
Discussion
Altered neuronal network activity in AD has been observed in several cerebral amyloidosis mouse models and AD patients5,6,11,12,20,29,46,47. Recent reports suggest that inhibitory circuits are particularly vulnerable, resulting in E/I imbalance and circuit-level dysfunction in AD19,29,48,49. However, the exact nature of the disrupted inhibitory activity is not yet fully understood in vivo. We report cell-type-specific interneuron dysfunction during spontaneous activity recorded in vivo in APP/PS1 mice. SOM interneurons were hyperactive while PV interneurons were hypoactive. Additionally, the changes in SOM interneuron activity, but not PV activity, correlated with proximity to amyloid plaques. These inhibitory deficits were accompanied by a decrease in excitatory neuronal activity, thus providing a detailed picture of the nature of E/I imbalance in the APP/PS1 mouse model.
Our finding of decreased excitatory neuronal activity in APP/PS1 mice may appear to conflict with reports of hyperactivity in amyloidosis models5,20,50. This discrepancy could be related to differences in animal model strains. Amyloidosis models such as APP/PS1 mice on C57BL/6J background20 exhibit seizures51. Genetic background is known to influence susceptibility to seizures in amyloidosis models52, and it is unclear if the seizure phenotype reported in C57BL/6J APP/PS1 mice would also be observed in APP/PS1 mice on C57BL/6;C3H background used in the current study53. Since seizures could be accompanied by increased excitability of pyramidal cells51,54, higher seizure incidence could result in a dominant hyperactivity phenotype in an amyloidosis mouse model. Furthermore, in agreement with our PV and excitatory cells findings, the initial reports of the hyperactivity phenotype also reported an increased fraction of hypoactive cells5,55. On the other hand, the decrease in spontaneous activity of PV interneurons reported in this study using the deconvolution method is in agreement with previous reports linking PV interneuron deficits to gamma rhythm disruption in AD6,27,29,30,56. It is important to note that our PV findings are limited and uncertain since the peak counting method did not show a significant effect. Future studies should measure PV interneuron firing rates in AD models using in vivo electrophysiological recordings to validate our findings.
Mounting evidence from in vivo and in vitro studies has shown that circuit activity is homeostatically regulated to maintain neuronal firing rates constrained to a particular functional limit57,58. Hence, neuronal circuits will respond to changes in firing activity, particularly in excitatory cells, with compensatory mechanisms to restore the perturbed firing homeostasis57,58. The process of restoring firing homeostasis involves two well-documented mechanisms. One, the circuit can adjust synaptic strength by gradually changing the ratio of inhibitory and excitatory synapses in the direction that normalizes the perturbation, or two, it can modify the intrinsic excitability to balance synaptic input and firing rates57.
We provide evidence for the failure of homeostatic mechanisms to maintain appropriate neuronal firing in APP/PS1 mice. Because the hyperactivity of SOM interneurons correlates with proximity to amyloid plaques SOM interneurons can potentially drive this dyshomeostasis since they supply aberrant inhibition to layer 2/3 pyramidal cells26,59,60. SOM interneurons were also reported to strongly inhibit PV interneurons in cortical layers 2/3 during visual processing61. SOM interneuron hyperactivity could thus suppress PV interneuron firing in APP/PS1 mice. Indeed, we saw hypoactivity within PV interneurons.
In addition to the synaptic mechanisms, alterations in the intrinsic excitability of different cell types can account for the changes in their activity patterns57. While the evidence for altered intrinsic excitability of excitatory cells in amyloidosis mouse models has been inconsistent19,62,63, a decrease in intrinsic excitability of pyramidal cells could potentially account for their hypoactivity in APP/PS1 mice.
Our results have important implications for future studies targeting the inhibitory circuit as a treatment strategy for AD. While inhibitory circuit deficits are prevalent in AD, it is not clear whether a therapeutic strategy that broadly restores inhibitory tone, using GABA agonists or antagonists, would benefit early-stage to intermediate-stage AD patients. Our results suggest that a more targeted approach to restoring inhibitory tone will be needed to overcome these network deficits since interneuron cell types were differentially affected by AD pathology. Future studies using approaches to control neuronal activity, such as optogenetics, should aim to decrease SOM or increase PV interneurons activity. Indeed, several studies have targeted PV interneurons activation using optogenetic and pharmacological approaches to restore oscillatory gamma activity and improve cognitive functions in preclinical animal models27,30,56,64.
Our study assumes that the Ca+2 indicator (GCaMP) concentration distribution across cells in different models is similar. A violation of this assumption could result in inaccurate estimation of event rates due to changes in indicator sensitivity and potentially cellular Ca+2 buffering capacity65. We opted to perform our experiments under low isoflurane anesthesia to reduce experimental variability66 and compare our findings to previous reports of altered single-cell activity in AD5,20. However, anesthesia is known to reduce neuronal activity and presents a limitation to our current findings44. Therefore, future experiments should include reproducing these findings in awake behaving animals using calcium imaging and multi-electrode array electrophysiology.
Together, these findings show an association between amyloid pathology and interneuron-related circuit deficits in an Alzheimer’s disease mouse model. These results should guide future therapeutic approaches targeting circuit dysfunction at the early to intermediate stages of Alzheimer’s disease.
Methods
Animals
All experimental procedures were approved by MGH Institutional Animal Care and Use Committee (IACUC). We crossed homozygote APPswe/PSdE9 transgenic mice overexpressing the amyloid precursor protein with the Swedish mutation and deltaE9 mutation in presenilin 1 (APP/PS1) (Stock #034829, C57BL/6;C3H genetic background, The Jackson Laboratory)67 with homozygote SOM-IRES-Cre knock-in mice (Stock #013044, The Jackson Laboratory)68 or homozygote PV-Cre mice (Stock # 008069, The Jackson Laboratory)69 to generate APP-SOM and APP-PV mice, respectively. Age-matched non-transgenic littermates were used as controls (WT-SOM and WT-PV). Experiments were performed in 8–11-month-old animals including males and females. Prior to any surgical procedures, animals of the same sex were housed in up to 4 animals/cage. Individual housing was maintained after surgical manipulation. All animals had ad libitum access to water and food and were maintained on a 12/12-hour day/night cycle in a pathogen-free environment.
Cranial window surgery and viral transduction of genetically encoded Ca indicator
Mice were initially anesthetized with 5% isoflurane inhalation in O2 and maintained on 1.5% isoflurane during the surgery. Throughout the procedure, mice were placed on a heating pad to keep the body temperature at ~37.5 °C and their eyes were protected with an ophthalmic ointment. A 5 mm craniotomy was drilled over the right somatosensory cortex using sterile technique. The dura was kept intact and wet with saline.
To express the ultrasensitive genetically encoded fluorescent calcium indicators in cortical inhibitory interneurons, we injected FLEX-jGCaMP7s (Addgene# 104491-AAV1)39 in SOM-CRE (4 × 1012 genome copies/ml) and PV-CRE (1 × 1012 genome copies/ml) WT and APP mice (n = 5–8 per group) at ~300 μm below the surface in the somatosensory cortex (2 sites, at 1.5- and 2.5-mm posterior to bregma and 2 mm lateral to the midline suture). We then used adeno-associated virus AAV1 carrying the construct GCaMP6s under the CaMKIIα promoter (Addgene# 107790-AAV9, 1 × 1012 genome copies/ml)40 to target excitatory cells of WT and APP mice (n = 9 per group). To ensure our excitatory neurons experiments are comparable to our interneurons experiments, CaMKIIα-GCaMP6s injections were targeted to a combination of PV-CRE (n = 5 per group) and SOM-CRE (n = 4 per group) WT and APP mice All the injections were delivered using a Hamilton syringe and Pump 11 Elite microsyringe pump (Harvard Apparatus) at a rate of 200 nl/min. Each injection consisted of ~1 μl of viral construct diluted in phosphate-buffered saline containing 0.01% Pluronic F-68. After injecting the desired volume, the Hamilton syringe was left at the injection site for 5 min to prevent backflow of the viral solution. A round glass coverslip (5 mm diameter) was placed over the right somatosensory cortex using a mix of dental cement and cyanoacrylate. Following each surgery, mice were housed individually and received analgesia (buprenorphine and acetaminophen) for 3 days postoperatively.
In vivo multiphoton calcium imaging
Imaging was performed under light isoflurane anesthesia to reduce experimental variability12. Mice were initially sedated with 5% isoflurane in room air using the SomnoSuite®Low-Flow Anesthesia System (Kent Scientific). Mice were then imaged under light anesthesia and low air-flow rates (1% isoflurane and ~40 mL/min air flow for a 30 g mouse). A heating pad was used to keep the animal’s body temperature at 37.5 °C, and ophthalmic ointment was used to protect the eyes. Animals were kept for at least 60 min under light isoflurane anesthesia before imaging. Mice typically showed an absence of tail-pinch reflex and a respiration rate of 80–120 breaths per minute during the imaging session.
A Fluoview FV1000MPE multiphoton microscope (Olympus) with a mode-locked MaiTai Ti:sapphire laser (Spectra-Physics) set to 900 nm was used for two-photon imaging. Spontaneous Ca2+ fluorescence signals from the somatosensory cortex were collected at 5 Hz through a 25x, 1.05 numerical aperture water immersion objective (Olympus) at 2x digital zoom. The Fluoview program was used to control the scanning and image acquisition (Olympus). Multiple fields of view (≈160 × 100 µm, 1 pixel per µm) were imaged per mouse, and each field of view was recorded for at least 100 s.
Calcium imaging data analysis
We used Suite2p70 and a custom-written MATLAB program to analyze spontaneous calcium events as follows. Recordings were collected as Olympus Image Format (OIF) files, converted to Tiff files using ImageJ, then imported to Suite2P for automated registration, somatic regions of interest (ROI) detection, and neuropil contamination estimation. We eliminated the neuropil contribution to emphasize neuronal soma signals. All images were aligned using the Suite2p rigid registration function that computes the shifts between each frame and a reference image using the phase correlation method. ROIs were automatically detected from the mean image for each recording using Suite2p anatomic detection methods. All automated ROIs were inspected manually, and missing ROIs were added. Fluorescence values were extracted from each ROI for each frame, and the mean for each cell was computed. In addition, neuropil contamination was estimated from at least 100 pixels surrounding each somatic ROI using Suite2p. This gave us two vectors of fluorescence values for the soma and the neuropil. Data were then analyzed using a custom-written MATLAB program (https://github.com/moustaam0/Algamal2022_analysis_w_OASIS) that was adopted from prior calcium imaging studies35 as described in the following paragraphs.
The neuropil vector was weighed a factor of 0.734. The weighted neuropil vector was subtracted from the somatic vector to produce a corrected vector of fluorescence values. The normalized ΔF/F trace was calculated according to the equation (Fi-F0)/F0), where Fi is the frame index, and F0 is the fluorescence baseline. To measure baseline F0 fluorescence in each cell, we employed a moving average baselining function like prior calcium imaging investigations35. The baselining function applies a sliding window of 250 frames (50 s) and quartile cut-off values ranging from the bottom tenth percentile to the median, depending on how active the neuron was. We then counted the total number of deconvolved events from the generated ΔF/F traces to estimate neuronal event rates using a robust non-negative deconvolution approach40 (https://github.com/zhoupc/OASIS_MATLAB). The deconvolution was employed using a FOOPSI Autoregressive model#1 (AR1) with the event size constrained to be 2.5 times the noise levels. GCaMP6/7s decay time was set at 1.25 s to estimate the ‘γ’ parameter, while sparsity penalty parameter (λ) was set to 0.
To calculate the correlation coefficients, deconvolved calcium events from each neuron were binarized and corrected for pixel timing using linear interpolation71. Correlation coefficients were then computed as the Pearson correlation coefficient (ρ) for all possible pairings of active neurons (event rate higher than 0.01 Hz) using MATLAB ‘corr’ function. All possible ρ values were pooled per experimental group to estimate the degree of synchrony. Distances between individual neurons represent the Euclidean distance between the ROI centroids. To estimate the effect of distance to each amyloid plaque on neuronal activity, we chose fields of view containing several neuronal cells and a single amyloid plaque in the same plane. Additionally, we made sure that no additional amyloid plaques were located within 100 µm in the x,y,z planes of the imaging field of view. Distances were then calculated as the Euclidean distances between the amyloid plaque center and the neuronal ROI centroid.
Immunohistochemistry
After the acquisition of multiphoton images, SOM-Cre and PV-Cre mice injected with FLEX-jGCaMP7s were euthanized using CO2 inhalation. Animals were then transcardially perfused, their brains collected and kept in 4% paraformaldehyde (PFA)/ phosphate buffered saline (PBS) solution overnight. The following day, brains were washed in PBS then transferred to a cryopreserving solution (30% sucrose in PBS). 40 µm thick coronal slices of mouse brains were subjected to antigen retrieval in citrate buffer. The sections were subsequently permeabilized with Triton X-100, blocked with normal goat serum (NGS), and incubated overnight at 4 °C with the following primary antibodies; PV (mouse monoclonal anti-PV, 1:500; Sigma P3088), SOM (rat polyclonal anti-SOM, 1:50; MAB354), or GFP (chicken polyclonal anti-GFP, 1:500, A10262). Tissue sections were then washed and incubated with their respective secondary antibodies (1:500) for 1 hour at room temperature. The slides were then mounted with Vectashield antifade mounting medium (Vector Laboratories). A Fluoview FV3000 confocal microscope (Olympus) with a ×40 objective was used to image PV and SOM-stained sections. Quantification of SOM and PV positive cells was done manually.
Statistics and reproducibility
The appropriate statistical test was chosen after the assessment of normal distribution using the Shapiro-Wilk normality test. In most cases, a non-parametric test was used because normal distribution could not be assumed. For comparison involving two experimental groups, we used either a parametric two-sided Student’s t test or a non-parametric Mann–Whitney t-test as detailed in the figure captions. Comparisons between three groups were assessed using Kruskal–Wallis one-way analysis of variance followed by a Dunn’s test to correct for multiple comparisons. Two-Way ANOVA was used to assess the relationship between inter-neuronal distances and pairwise neuronal activity correlations. Spearman correlation was used to assess the relationship between amyloid plaque distance and event rates. A p value of less than 0.05 was considered statistically significant. Individual animals were used to preform statistical analysis on all data presented in the main figures (5–9 mice per group).
Reporting summary
Further information on research design is available in the Nature Portfolio Reporting Summary linked to this article.
Supplementary information
Acknowledgements
This work was funded by NIA (RF1AG061774). Acknowledgement is made to the donors of the Alzheimer’s Disease Research Program, a program of the BrightFocus Foundation, for support of this research under grant A2021001F and Alzheimer’s Association under grant AARG-18-52336.
Author contributions
Conception and design of study (M.A., K.V.K., and B.J.B.), mouse surgery (M.A. and A.N.R.), in vivo imaging and maintenance of two-photon setup (M.A. and S.S.H.), data analysis (M.A. with help from M.M., L.M., and Q.Z.), coding and data interpretation (M.A.), immunohistochemistry (M.R.M.), manuscript preparation (M.A. with help from A.N.R., B.J.B., and K.V.K.), securing funding (K.V.K., B.J.B., and D.G.) and project supervision (B.J.B. and K.V.K.).
Peer review
Peer review information
Communications Biology thanks the anonymous reviewers for their contribution to the peer review of this work. Primary Handling Editor: Joao Valente. Peer reviewer reports are available.
Data availability
All data needed to drive the conclusions of this article are present in the paper and the Supplementary Information. Additionally, numerical source data for main figures and all unprocessed calcium traces (MATLAB source files) are available72,73 at https://figshare.com/account/home#/collections/6290574.
Code availability
The MATLAB code used to generate data presented in this article available at (https://github.com/moustaam0/Algamal2022_analysis_w_OASIS).
Competing interests
The authors declare no competing interests.
Footnotes
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Contributor Information
Brian J. Bacskai, Email: BBACSKAI@mgh.harvard.edu
Ksenia V. Kastanenka, Email: KKASTANENKA@mgh.harvard.edu
Supplementary information
The online version contains supplementary material available at 10.1038/s42003-022-04268-x.
References
- 1.Lane CA, Hardy J, Schott JM. Alzheimer’s disease. Eur. J. Neurol. 2018;25:59–70. doi: 10.1111/ene.13439. [DOI] [PubMed] [Google Scholar]
- 2.Hyman BT, et al. National Institute on Aging-Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease. Alzheimer’s Dement. 2012;8:1–13. doi: 10.1016/j.jalz.2011.10.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Selkoe DJ, Hardy J. The amyloid hypothesis of Alzheimer’s disease at 25 years. EMBO Mol. Med. 2016;8:595–608. doi: 10.15252/emmm.201606210. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Vossel KA, et al. Incidence and impact of subclinical epileptiform activity in Alzheimer’s disease. Ann. Neurol. 2016;80:858–870. doi: 10.1002/ana.24794. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Busche, M. A. et al. Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer’s disease. Science10.1126/science.1162844 (2008). [DOI] [PubMed]
- 6.Palop JJ, et al. Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer’s disease. Neuron. 2007;55:697–711. doi: 10.1016/j.neuron.2007.07.025. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Lee, Y. F., Gerashchenko, D., Timofeev, I., Bacskai, B. J. & Kastanenka, K. V. Slow Wave Sleep Is a Promising Intervention Target for Alzheimer’s Disease. Front. Neurosci.14, 705 (2020). [DOI] [PMC free article] [PubMed]
- 8.Kastanenka KV, et al. Optogenetic restoration of disrupted slow oscillations halts amyloid deposition and restores calcium homeostasis in an animal model of Alzheimer’s disease. PLoS One. 2017;12:1–25. doi: 10.1371/journal.pone.0170275. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Mander BA, et al. β-amyloid disrupts human NREM slow waves and related hippocampus-dependent memory consolidation. Nat. Neurosci. 2015;18:1051–1057. doi: 10.1038/nn.4035. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Jelles B, et al. Global dynamical analysis of the EEG in Alzheimer’s disease: frequency-specific changes of functional interactions. Clin. Neurophysiol. 2008;119:837–841. doi: 10.1016/j.clinph.2007.12.002. [DOI] [PubMed] [Google Scholar]
- 11.Vossel KA, et al. Seizures and epileptiform activity in the early stages of Alzheimer disease. JAMA Neurol. 2013;70:1158–1166. doi: 10.1001/jamaneurol.2013.136. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Sperling RA, et al. Functional alterations in memory networks in early Alzheimer’s disease. NeuroMolecular Med. 2010;12:27–43. doi: 10.1007/s12017-009-8109-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Steriade M, McCormick DA, Sejnowski TJ. Thalamocortical oscillations in the sleeping and aroused brain. Science. 1993;262:679–685. doi: 10.1126/science.8235588. [DOI] [PubMed] [Google Scholar]
- 14.Buzsáki G, Anastassiou CA, Koch C. The origin of extracellular fields and currents — EEG, ECoG, LFP and spikes. Nat. Rev. Neurosci. 2012;13:407–420. doi: 10.1038/nrn3241. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Lin, A., Liu, K. K. L., Bartsch, R. P. & Ivanov, P. C. Dynamic network interactions among distinct brain rhythms as a hallmark of physiologic state and function. Commun Biol3, 197 (2020). [DOI] [PMC free article] [PubMed]
- 16.Martinez-Losa M, et al. Nav1.1-overexpressing interneuron transplants restore brain rhythms and cognition in a mouse model of Alzheimer’s disease. Neuron. 2018;98:75–89.e5. doi: 10.1016/j.neuron.2018.02.029. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Petrache AL, et al. Aberrant excitatory-inhibitory synaptic mechanisms in entorhinal cortex microcircuits during the pathogenesis of Alzheimer’s disease. Cereb. Cortex. 2019;29:1834–1850. doi: 10.1093/cercor/bhz016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Hanson JE, et al. GluN2A NMDA receptor enhancement improves brain oscillations, synchrony, and cognitive functions in dravet syndrome and Alzheimer’s disease models. Cell Rep. 2020;30:381–396.e4. doi: 10.1016/j.celrep.2019.12.030. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Hijazi S, et al. Early restoration of parvalbumin interneuron activity prevents memory loss and network hyperexcitability in a mouse model of Alzheimer’s disease. Mol. Psychiatry. 2020;25:3380–3398. doi: 10.1038/s41380-019-0483-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Busche MA, et al. Tau impairs neural circuits, dominating amyloid-β effects, in Alzheimer models in vivo. Nat. Neurosci. 2019;22:57–64. doi: 10.1038/s41593-018-0289-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Klee JL, Kiliaan AJ, Lipponen A, Battaglia FP. Reduced firing rates of pyramidal cells in the frontal cortex of APP/PS1 can be restored by acute treatment with levetiracetam. Neurobiol. Aging. 2020;96:79–86. doi: 10.1016/j.neurobiolaging.2020.08.013. [DOI] [PubMed] [Google Scholar]
- 22.Meinecke DL, Peters A. GABA immunoreactive neurons in rat visual cortex. J. Comp. Neurol. 1987;261:388–404. doi: 10.1002/cne.902610305. [DOI] [PubMed] [Google Scholar]
- 23.Fino E, Packer AM, Yuste R. The logic of inhibitory connectivity in the neocortex. Neuroscientist. 2013;19:228–237. doi: 10.1177/1073858412456743. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Isaacson JS, Scanziani M. How inhibition shapes cortical activity. Neuron. 2011;72:231–243. doi: 10.1016/j.neuron.2011.09.027. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Meyer HS, et al. Inhibitory interneurons in a cortical column form hot zones of inhibition in layers 2 and 5A. Proc. Natl Acad. Sci. USA. 2011;108:16807–16812. doi: 10.1073/pnas.1113648108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Tremblay R, Lee S, Rudy B. GABAergic interneurons in the neocortex: from cellular properties to circuits. Neuron. 2016;91:260–292. doi: 10.1016/j.neuron.2016.06.033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Palop JJ, Mucke L. Network abnormalities and interneuron dysfunction in Alzheimer disease. Nat. Rev. Neurosci. 2016;17:777–792. doi: 10.1038/nrn.2016.141. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Schmid LC, et al. Dysfunction of somatostatin-positive interneurons associated with memory deficits in an Alzheimer’s Disease model. Neuron. 2016;92:114–125. doi: 10.1016/j.neuron.2016.08.034. [DOI] [PubMed] [Google Scholar]
- 29.Verret L, et al. Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in alzheimer model. Cell. 2012;149:708–721. doi: 10.1016/j.cell.2012.02.046. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Martinez-Losa M, et al. Nav1.1-overexpressing interneuron transplants restore brain rhythms and cognition in a mouse model of Alzheimer’s disease. Neuron. 2018;98:75–89.e5. doi: 10.1016/j.neuron.2018.02.029. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Orr AL, et al. β-Amyloid inhibits E-S potentiation through suppression of cannabinoid receptor 1-dependent synaptic disinhibition. Neuron. 2014;82:1334–1345. doi: 10.1016/j.neuron.2014.04.039. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Olah, V. J. et al. Biophysical Kv3 channel alterations dampen excitability of cortical PV interneurons and contribute to network hyperexcitability in early Alzheimer’s. Elife11, e75316 (2022). [DOI] [PMC free article] [PubMed]
- 33.Yasuda, R. et al. Imaging calcium concentration dynamics in small neuronal compartments. Science’s STKE2004, pl5 (2004). [DOI] [PubMed]
- 34.Chen, T.-W. et al. Ultra-sensitive Fluorescent Proteins For Imaging Neuronal Activity. vol. 499 http://www.nature.com/authors/editorial_policies/license.html#terms (2013). [DOI] [PMC free article] [PubMed]
- 35.Chen Q, et al. Dysfunction of cortical GABAergic neurons leads to sensory hyper-reactivity in a Shank3 mouse model of ASD. Nat. Neurosci. 2020;23:520–532. doi: 10.1038/s41593-020-0598-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Deneux T, et al. Accurate spike estimation from noisy calcium signals for ultrafast three-dimensional imaging of large neuronal populations in vivo. Nat. Commun. 2016;7:1–17. doi: 10.1038/ncomms12190. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Sebastian, J. et al. GDspike: an accurate spike estimation algorithm from noisy calcium fluorescence signals. ICASSP, IEEE International Conference on Acoustics, Speech and Signal Processing - Proceedings. p. 1043–1047 10.1109/ICASSP.2017.7952315 (2017).
- 38.Theis L, et al. Benchmarking spike rate inference in population calcium imaging. Neuron. 2016;90:471–482. doi: 10.1016/j.neuron.2016.04.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Vogelstein JT, et al. Fast nonnegative deconvolution for spike train inference from population calcium imaging. J. Neurophysiol. 2010;104:3691–3704. doi: 10.1152/jn.01073.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Friedrich, J., Zhou, P. & Paninski, L. Fast online deconvolution of calcium imaging data. PLoS Comput. Biol.13, e1005423 (2017). [DOI] [PMC free article] [PubMed]
- 41.Pachitariu M, Stringer C, Harris KD. Robustness of spike deconvolution for neuronal calcium imaging. J. Neurosci. 2018;38:7976–7985. doi: 10.1523/JNEUROSCI.3339-17.2018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Wonders CP, Anderson SA. The origin and specification of cortical interneurons. Nat. Rev. Neurosci. 2006;7:687–696. doi: 10.1038/nrn1954. [DOI] [PubMed] [Google Scholar]
- 43.Korzhova V, et al. Long-term dynamics of aberrant neuronal activity in awake Alzheimer’s disease transgenic mice. Commun. Biol. 2021;4:1368. doi: 10.1038/s42003-021-02884-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Lissek, T. et al. General anesthetic conditions induce network synchrony and disrupt sensory processing in the cortex. Front. Cell. Neurosci.10, 64 (2016). [DOI] [PMC free article] [PubMed]
- 45.Cohen MR, Kohn A. Measuring and interpreting neuronal correlations. Nat. Neurosci. 2011;14:811–819. doi: 10.1038/nn.2842. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Scarmeas N, et al. Seizures in Alzheimer Disease: Who, When, and How Common? Arch. Neurol. 2009;66:992–997. doi: 10.1001/archneurol.2009.130. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Korzhova, V. et al. Long-term dynamics of aberrant neuronal activity in awake Alzheimer’s disease transgenic mice. [DOI] [PMC free article] [PubMed]
- 48.Lei M, et al. Soluble Aβ oligomers impair hippocampal LTP by disrupting glutamatergic/GABAergic balance. Neurobiol. Dis. 2016;85:111–121. doi: 10.1016/j.nbd.2015.10.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Busche, M. A. & Konnerth, A. Impairments of neural circuit function in Alzheimer’s disease. Philosophical Transactions of the Royal Society B: Biological Sciences.371, 1700 (2016). [DOI] [PMC free article] [PubMed]
- 50.Busche MA, et al. Decreased amyloid-β and increased neuronal hyperactivity by immunotherapy in Alzheimer’s models. Nat. Neurosci. 2015;18:1725–1727. doi: 10.1038/nn.4163. [DOI] [PubMed] [Google Scholar]
- 51.Minkeviciene R, et al. Amyloid β-induced neuronal hyperexcitability triggers progressive epilepsy. J. Neurosci. 2009;29:3453–3462. doi: 10.1523/JNEUROSCI.5215-08.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Jackson HM, et al. DBA/2J genetic background exacerbates spontaneous lethal seizures but lessens amyloid deposition in a mouse model of Alzheimer’s disease. PLoS ONE. 2015;10:e0125897. doi: 10.1371/journal.pone.0125897. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.The Jackson Laboratory. https://www.jax.org/strain/005864. (2021).
- 54.Xu, M. et al. DV21 decreases excitability of cortical pyramidal neurons and acts in epilepsy /631/378 /692/617 /9/74 article. Sci. Rep.7, 1701 (2017). [DOI] [PMC free article] [PubMed]
- 55.Grienberger, C. et al. Staged decline of neuronal function in vivo in an animal model of Alzheimer’s disease. Nat Commun3, 774 (2012). [DOI] [PMC free article] [PubMed]
- 56.Iaccarino HF, et al. Gamma frequency entrainment attenuates amyloid load and modifies microglia. Nature. 2016;540:230–235. doi: 10.1038/nature20587. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Turrigiano G. Too many cooks? Intrinsic and synaptic homeostatic mechanisms in cortical circuit refinement. Annu. Rev. Neurosci. 2011;34:89–103. doi: 10.1146/annurev-neuro-060909-153238. [DOI] [PubMed] [Google Scholar]
- 58.Styr B, Slutsky I. Imbalance between firing homeostasis and synaptic plasticity drives early-phase Alzheimer’s disease. Nat. Neurosci. 2018;21:463–473. doi: 10.1038/s41593-018-0080-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Gentet LJ, et al. Unique functional properties of somatostatin-expressing GABAergic neurons in mouse barrel cortex. Nat. Neurosci. 2012;15:607–612. doi: 10.1038/nn.3051. [DOI] [PubMed] [Google Scholar]
- 60.Fanselow EE, Kubota Y, Wehr M, Yavorska I. Somatostatin-expressing inhibitory interneurons in cortical circuits. Front. Neural Circuits. 2016;10:76. doi: 10.3389/fncir.2016.00076. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Cottam JCH, Smith SL, Häusser M. Target-specific effects of somatostatin-expressing interneurons on neocortical visual processing. J. Neurosci. 2013;33:19567–19578. doi: 10.1523/JNEUROSCI.2624-13.2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Kerrigan TL, Brown JT, Randall AD. Characterization of altered intrinsic excitability in hippocampal CA1 pyramidal cells of the Aβ-overproducing PDAPP mouse. Neuropharmacology. 2014;79:515–524. doi: 10.1016/j.neuropharm.2013.09.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Zhang XQ, et al. Reduced synaptic transmission and intrinsic excitability of a subtype of pyramidal neurons in the medial prefrontal cortex in a mouse model of Alzheimer’s disease. J. Alzheimer’s Dis. 2021;84:129–140. doi: 10.3233/JAD-210585. [DOI] [PubMed] [Google Scholar]
- 64.Park, K. et al. Optogenetic activation of parvalbumin and somatostatin interneurons selectively restores theta-nested gamma oscillations and oscillation-induced spike timing-dependent long-Term potentiation impaired by amyloid β oligomers. BMC Biol.18, 7 (2020). [DOI] [PMC free article] [PubMed]
- 65.Rose, T., Goltstein, P. M., Portugues, R. & Griesbeck, O. Putting a finishing touch on GECIs. Frontiers in Molecular Neuroscience.7, 88 (2014). [DOI] [PMC free article] [PubMed]
- 66.Froudarakis E, et al. Population code in mouse V1 facilitates readout of natural scenes through increased sparseness. Nat. Neurosci. 2014;17:851–857. doi: 10.1038/nn.3707. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Jankowsky JL, et al. Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum. Mol. Genet. 2004;13:159–170. doi: 10.1093/hmg/ddh019. [DOI] [PubMed] [Google Scholar]
- 68.Taniguchi H, et al. A resource of Cre driver lines for genetic targeting of GABAergic neurons in cerebral cortex. Neuron. 2011;71:995–1013. doi: 10.1016/j.neuron.2011.07.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Hippenmeyer S, et al. A developmental switch in the response of DRG neurons to ETS transcription factor signaling. PLoS Biol. 2005;3:0878–0890. doi: 10.1371/journal.pbio.0030159. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Pachitariu, M. et al. Suite2p: beyond 10,000 neurons with standard two-photon microscopy. bioRxiv 061507. 10.1101/061507 (2017).
- 71.Boiroux D, Oke Y, Miwakeichi F, Oku Y. Pixel timing correction in time-lapsed calcium imaging using point scanning microscopy. J. Neurosci. Methods. 2014;237:60–68. doi: 10.1016/j.jneumeth.2014.08.008. [DOI] [PubMed] [Google Scholar]
- 72.Algamal, M. Matlab source files for Algamal et al 2020. figshare. Dataset 10.6084/m9.figshare.19740019.v1 (2022).
- 73.Algamal, M. Numerical data for main figures (Algamal et al 2022). figshare. Dataset 10.6084/m9.figshare.21525966.v1 (2022).
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
All data needed to drive the conclusions of this article are present in the paper and the Supplementary Information. Additionally, numerical source data for main figures and all unprocessed calcium traces (MATLAB source files) are available72,73 at https://figshare.com/account/home#/collections/6290574.
The MATLAB code used to generate data presented in this article available at (https://github.com/moustaam0/Algamal2022_analysis_w_OASIS).